Technical Analysis for TBIO - Telesis Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.31 | -65.80% | -2.52 |
Earnings due: Nov 11
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | -65.80% | |
| Crossed Above 50 DMA | Bullish | -65.80% | |
| Outside Day | Range Expansion | -65.80% | |
| Wide Bands | Range Expansion | -65.80% | |
| Gapped Down | Weakness | -65.80% | |
| Fell Below 50 DMA | Bearish | -59.44% | |
| 20 DMA Support | Bullish | -59.44% | |
| Calm After Storm | Range Contraction | -59.44% | |
| Wide Bands | Range Expansion | -59.44% | |
| Gapped Down | Weakness | -59.44% |
| Alert | Time |
|---|---|
| Possible NR7 | about 20 hours ago |
| Down 5% | about 23 hours ago |
| Down 3% | about 23 hours ago |
| Fell Below 50 DMA | about 23 hours ago |
| Fell Below Previous Day's Low | about 23 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/11/2024
Telesis Bio, Inc. Description
Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology Gene Expression Synthetic Biology Molecular Genetics Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.06 |
| 52 Week Low | 1.27 |
| Average Volume | 1,894,885 |
| 200-Day Moving Average | 5.50 |
| 50-Day Moving Average | 3.46 |
| 20-Day Moving Average | 2.88 |
| 10-Day Moving Average | 2.84 |
| Average True Range | 0.90 |
| RSI (14) | 55.75 |
| ADX | 37.62 |
| +DI | 44.64 |
| -DI | 16.85 |
| Chandelier Exit (Long, 3 ATRs) | 2.48 |
| Chandelier Exit (Short, 3 ATRs) | 3.96 |
| Upper Bollinger Bands | 4.81 |
| Lower Bollinger Band | 0.96 |
| Percent B (%b) | 0.75 |
| BandWidth | 133.64 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.22 |
| MACD Histogram | 0.1892 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.86 | ||||
| Resistance 3 (R3) | 5.67 | 4.81 | 5.52 | ||
| Resistance 2 (R2) | 4.81 | 4.29 | 4.90 | 5.40 | |
| Resistance 1 (R1) | 4.32 | 3.98 | 4.57 | 4.51 | 5.29 |
| Pivot Point | 3.46 | 3.46 | 3.58 | 3.55 | 3.46 |
| Support 1 (S1) | 2.97 | 2.94 | 3.22 | 3.16 | 2.37 |
| Support 2 (S2) | 2.11 | 2.63 | 2.20 | 2.26 | |
| Support 3 (S3) | 1.62 | 2.11 | 2.14 | ||
| Support 4 (S4) | 1.81 |
